Skip to content

Testing The effect of Shilajatu Vataka Tablet In Patients Of Iron Defeciency Anaemia

Potentiation Of Shilajatu Vataka With Two Different Bhavana Durations And Its Clinical Validation In Pandu With Special Reference To Iron Defeciency Anaemia - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/097723
Enrollment
60
Registered
2025-11-20
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D508- Other iron deficiency anemias

Interventions

None listed

Sponsors

Government PG Ayurvedic College and Hospital, Chaukaghat, Varanasi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patient Of Age Group 16 To 60 Years Irrespective of Gender, Religion , Occupation. 2) Patients Having Sign And Symptomps Of Pandu Roga Without Having Any Complications. 3)Haemoglobin Percentage In between 8 gm/dl to 11 gm/dl. 4)Patients With Samanya Lakshan Of Pandu Roga.

Exclusion criteria

Exclusion criteria: 1) Patients Suffering From Tuberculosis , Diabetes Mellitus, or Other Severe Disease. 2) Age Below 16 Years And Above 60 Years. 3) Haemoglobin Less Than 7.9 mg/dl. 4) Pregnant And Lactating women. 5) Anaemia Due To Other Causes Than Iron Defeciency like Thalessaemia , Sickle Cell Anaemia, Anaemia due To Bleeding Disorders .

Design outcomes

Primary

MeasureTime frame
Improvement In Anaemia.Timepoint: 15 DAYS , 30 DAYS , 45 DAYS

Secondary

MeasureTime frame
Complete Improvement In Anaemia.Timepoint: 45 Days

Countries

India

Contacts

Public ContactDR Shweta Mishra

Government PG Ayurvedic College and Hospital

richapathak384@gmail.com8948883359

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026